NCT02239562View on ClinicalTrials.gov

sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 14, 2014

Primary Completion Date

April 25, 2016

Study Completion Date

December 29, 2016

Conditions
Autoimmune Hepatitis
Interventions
DRUG

sPIF

DRUG

Placebo

Trial Locations (2)

33136

Center for Liver Diseases; University of Miami, Miami

08003-3157

Chief Scientist, BIOINCEPT, LLC / Chairman, (SIEP) / Director, Ob&Gyn CAMcare Health Center, Cherry Hill

Sponsors

Collaborators (1)

BioIncept LLC
All Listed Sponsors
collaborator

BioIncept LLC

INDUSTRY

lead

Christopher O'Brien, MD

OTHER

NCT02239562 - sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS | Biotech Hunter | Biotech Hunter